Versor Investments LP Invests $278,000 in Aspen Aerogels, Inc. $ASPN

Key Points

• Versor Investments LP has purchased 43,500 shares of Aspen Aerogels, valued at approximately $278,000, reflecting a small stake of 0.05% in the company.
• Institutional investors collectively own 97.64% of Aspen Aerogels, with significant increases in positions from firms like Allspring Global Investments and BNP Paribas Financial Markets.
• Aspen Aerogels reported a loss of ($0.04) EPS for the quarter, surpassing analyst estimates, while revenue decreased by 33.8% year-over-year to $78.02 million.

Versor Investments LP bought a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The fund bought 43,500 shares of the construction company's stock, valued at approximately $278,000. Versor Investments LP owned 0.05% of Aspen Aerogels at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of ASPN. Vanguard Group Inc. lifted its stake in shares of Aspen Aerogels by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 4,373,159 shares of the construction company's stock worth $27,944,000 after purchasing an additional 12,913 shares during the period. Oaktop Capital Management II L.P. lifted its position in shares of Aspen Aerogels by 5.6% during the fourth quarter. Oaktop Capital Management II L.P. now owns 3,740,525 shares of the construction company's stock worth $44,437,000 after purchasing an additional 200,000 shares during the last quarter. Needham Investment Management LLC lifted its position in shares of Aspen Aerogels by 5.2% during the fourth quarter. Needham Investment Management LLC now owns 2,389,700 shares of the construction company's stock worth $28,390,000 after purchasing an additional 117,500 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in Aspen Aerogels by 25.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,018,631 shares of the construction company's stock worth $23,983,000 after acquiring an additional 409,862 shares during the last quarter. Finally, Millennium Management LLC grew its stake in Aspen Aerogels by 4,757.8% during the 4th quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company's stock worth $19,270,000 after buying an additional 1,588,632 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Stock Down 0.5%

Shares of Aspen Aerogels stock traded down $0.04 during trading on Wednesday, reaching $7.09. 241,233 shares of the company traded hands, compared to its average volume of 2,015,994. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $30.24. The firm has a market capitalization of $583.52 million, a PE ratio of -1.86 and a beta of 2.73. The company has a 50 day moving average price of $6.95 and a 200-day moving average price of $6.69. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.08. The company had revenue of $78.02 million during the quarter, compared to analyst estimates of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. Aspen Aerogels's revenue was down 33.8% compared to the same quarter last year. During the same period last year, the business earned $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, equities research analysts expect that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Insider Activity at Aspen Aerogels

In related news, CAO Santhosh P. Daniel sold 4,410 shares of the company's stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the transaction, the chief accounting officer owned 19,879 shares in the company, valued at $145,315.49. The trade was a 18.16% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 3.40% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on ASPN shares. Oppenheimer downgraded Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th. Canaccord Genuity Group dropped their price objective on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Finally, Barclays cut shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and increased their price target for the company from $7.00 to $16.00 in a research note on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $19.50.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.